Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells

E-ISSN： 1791-2423|46|3|963-972

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.3, 2015-01, pp. : 963-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2609-2612

Spandidos Publications

Access to resources Recommend Favorite

Proteasome inhibitors in the treatment of multiple myeloma

By McBride Ali Ryan Patricia Y

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 339-358

Informa Healthcare

Access to resources Recommend Favorite

Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stressmediated cell death in multiple myeloma cells

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 474-486

Spandidos Publications

Access to resources Recommend Favorite

IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells

By Patterson Jon Palombella Vito Fritz Christian Normant Emmanuel

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 923-932

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenic Activity of Mesenchymal Stem Cells in Multiple Myeloma

By Wang Xiaofang Zhang Zhiqing Yao Cheng

Cancer Investigation, Vol. 29, Iss. 1, 2011-01 ,pp. : 37-41

Informa Healthcare

Access to resources Recommend Favorite